GOCO
GoHealth, Inc.
$0.2995
-6.41%
$9.4M
No data for this timeframe.
Vol
Market Cap$9.4M
Cap SizeNano Cap
Inst. Holders6 funds
Inst. Value$795.5K
Inst. Activity4 buys / 1 sells
SEC Reports2
Press Releases1
Exchange Nasdaq·Sector Insurance Agents, Brokers & Service·Inc. DE·CIK 0001808220·Prev Close $0.3200
Recent Activity
Jun 8, 2026
SEC
GoHealth filed voluntary Chapter 11 petitions to implement a prepackaged restructuring plan supported by 100% of lenders
8-K — Impact 8/10
Apr 21, 2026
SEC
GoHealth reported full-year 2025 results with a net loss of $497.8 million, a 6,700% year-over-year deterioration, drive
8-K — Impact 8/10
Inst.
CHARLES SCHWAB INVESTMENT MANAGEMENT — DOUBLED
26,448 shares ($56.9K)
Inst.
FMR LLC — DOUBLED
13,983 shares ($30.1K)
Jun 7, 2026
Press
GoHealth has initiated a voluntary prepackaged Chapter 11 restructuring with support from 100% of its lenders, over 60%
Impact 9/10
Jun 7, 2026
regulatory
GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders
<p align="center"><em>Initiates voluntary prepackaged Chapter 11 process to implement Restructuring
Price Targets
Historical data — last covering-analyst action Nov 2025. No current recommendation available.
$5.13 (Nov 2025)
Current $0.2995
Low $1.50
Median $4.50
High $10.00
4 analysts
$1.50
$10.00
Analyst Ratings
2Strong Buy
4Buy
4Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 26, 2025 | RBC Capital | MAINTAIN | Sector Perform → Sector Perform |
| Nov 20, 2025 | Freedom Broker | MAINTAIN | Buy → Buy |
| Nov 19, 2025 | William Blair | DOWNGRADE | Outperform → Market Perform |
| Aug 28, 2025 | RBC Capital | MAINTAIN | Sector Perform → Sector Perform |
| May 19, 2025 | RBC Capital | REITERATE | Sector Perform → Sector Perform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-1.58 ▲ +23.6% | $-1.65 — $-1.49 | 69% YoY | 3 |
| Next Q | $-1.57 ▲ +22.2% | $-1.69 — $-1.35 | 87% YoY | 3 |
| Current FY | $-5.33 ▲ +25.6% | $-6.02 — $-4.65 | 74% YoY | 2 |
| Next FY | $-3.56 ▲ +18.8% | $-6.95 — $-1.16 | 33% YoY | 5 |
Latest Reports
BEARISH
8-K
8/10
GoHealth filed voluntary Chapter 11 petitions to implement a prepackaged restructuring plan supported by 100% of lenders
Jun 8, 2026
BEARISH
Press
9/10
GoHealth has initiated a voluntary prepackaged Chapter 11 restructuring with support from 100% of its lenders, over 60%
Jun 7, 2026
BEARISH
8-K
8/10
GoHealth reported full-year 2025 results with a net loss of $497.8 million, a 6,700% year-over-year deterioration, drive
Apr 21, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $615.3K | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $56.9K | DOUBLED |
| MORGAN STANLEY | $44.9K | TRIM |
| FMR LLC | $30.1K | DOUBLED |
| BANK OF AMERICA CORP | $25.4K | DOUBLED |
6 institutional holders with $795.5K total value (369,990 shares) as of 2025-Q4. Top holders: VANGUARD, CHARLES, MORGAN. Net buying activity: 4 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 286,205 | $615.3K | 77.4% | — |
| 2 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 26,448 | $56.9K | 7.1% | DOUBLED +119.3% |
| 3 | MORGAN STANLEY | 20,864 | $44.9K | 5.6% | TRIM -63.3% |
| 4 | FMR LLC | 13,983 | $30.1K | 3.8% | DOUBLED +2009.0% |
| 5 | BANK OF AMERICA CORP /DE/ | 11,827 | $25.4K | 3.2% | DOUBLED +272.2% |
| 6 | WELLS FARGO & COMPANY/MN | 10,663 | $22.9K | 2.9% | DOUBLED +153.3% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | DOUBLED | 12,060 | 26,448 | +119.3% | $56.9K | 2025-Q4 |
| FMR LLC | DOUBLED | 663 | 13,983 | +2009.0% | $30.1K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 3,178 | 11,827 | +272.2% | $25.4K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 4,209 | 10,663 | +153.3% | $22.9K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 48,778 | 0 | -100.0% | $0.00 | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 93,278 | 48,778 | -47.7% | $235.1K | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | ADD | 3,224 | 4,209 | +30.6% | $20.3K | 2025-Q3 |
| UBS Group AG | ADD | 1,812 | 3,408 | +88.1% | $16.4K | 2025-Q3 |
| FMR LLC | TRIM | 1,757 | 663 | -62.3% | $3.2K | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 60,378 | 93,278 | +54.5% | $517.7K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 64,918 | 23,826 | -63.3% | $132.2K | 2025-Q2 |
| FMR LLC | ADD | 1,007 | 1,757 | +74.5% | $9.8K | 2025-Q2 |
| MORGAN STANLEY | ADD | 51,296 | 64,918 | +26.6% | $796.5K | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 22,572 | 60,378 | +167.5% | $740.8K | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 49,613 | 27,036 | -45.5% | $331.7K | 2025-Q1 |
| UBS Group AG | TRIM | 5,258 | 2,380 | -54.7% | $29.2K | 2025-Q1 |
| CITADEL ADVISORS LLC | NEW | — | 49,613 | — | $664.3K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 2,153 | 2,760 | +28.2% | $37.0K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 15,371 | — | $144.2K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 0 mixed, 0 neutral. Avg impact: 8.0/10.
Historical analyst distribution (last covering-analyst action Nov 2025): 60% buy across 10 analysts — 2 strong buy, 4 buy, 4 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Nov 2025. No current recommendation available.
$5.13 mean target (Nov 2025)
$1.50 Low
$10.00 High
| Metric | Value |
|---|---|
| Current Price | $0.2995 |
| Target Low | $1.50 |
| Target Mean | $5.13 |
| Target Median | $4.50 |
| Target High | $10.00 |
| # Analysts | 4 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-1.58 | $-1.65 | $-1.49 | 69.0% | +23.6% | 0↑ 1↓ | $0.0B | -87.8% | 3 |
| Next Q 2026-09-30 |
$-1.57 | $-1.69 | $-1.35 | 86.7% | +22.2% | 1↑ 0↓ | $0.0B | -59.3% | 3 |
| Current FY 2026-12-31 |
$-5.33 | $-6.02 | $-4.65 | 73.6% | +25.6% | 0↑ 1↓ | $0.3B | -27.7% | 2 |
| Next FY 2027-12-31 |
$-3.56 | $-6.95 | $-1.16 | 33.4% | +18.8% | 1↑ 0↓ | $0.4B | 70.3% | 5 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-1.583 | |
| 7d ago | $-1.490 | -0.093 |
| 30d ago | $-2.073 | +0.490 |
| 60d ago | $-1.865 | +0.282 |
| 90d ago | $-1.986 | +0.403 |
4 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Nov 26, 2025 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Nov 20, 2025 | Freedom Broker | MAINTAIN | Buy | Buy |
| Nov 19, 2025 | William Blair | DOWNGRADE | Outperform | Market Perform |
| Aug 28, 2025 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| May 19, 2025 | RBC Capital | REITERATE | Sector Perform | Sector Perform |
| Mar 20, 2024 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Apr 4, 2023 | Credit Suisse | MAINTAIN | — | Underperform |
| Mar 17, 2023 | RBC Capital | MAINTAIN | — | Sector Perform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| May 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Apr 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| Mar 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| Feb 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% | |
| Jan 1, 2026 | 2 | 5 | 3 | 0 | 0 | 70% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 7, 2026
regulatory
GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders
<p align="center"><em>Initiates voluntary prepackaged Chapter 11 process to implement Restructuring Transactions that have the support of 100% of its
May 13, 2026
earnings_calendar
GOCO Q1 2026 Earnings Scheduled — 2026-05-13
May 11, 2026
earnings_calendar
GOCO Q1 2026 Earnings Scheduled — 2026-05-11
Mar 31, 2026
earnings
GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results
<p><em>Disciplined posture reflects consumer-first enrollment, an intentional Medicare Advantage pullback driven by market realities, continued specia
Mar 12, 2026
earnings_calendar
GOCO Q4 2025 Earnings After Market Close — 2026-03-12